Advanced Enzyme Technologies Limited (ADVENZYMES) Share Analysis
NSE · Healthcare · Healthcare
Advanced Enzyme Technologies Limited (NSE: ADVENZYMES) is an Indian listed company in the Healthcare sector and a constituent of NIFTY Microcap 250. As of 14 Nov 2026, the share price was ₹284.00, P/E 19.1, ROE 10.5%.
Get the AI verdict on ADVENZYMES: BUY, BUY ON DIPS, WAIT or EXIT
Sign in for the full analysis — AI fundamental and technical analysis, recent news, and one verdict with an entry zone, two targets and a stop-loss, for a 3-month, 1-year, 3-year or 5-year horizon. A free plan is available.
ADVENZYMES chart with trendlines
Is ADVENZYMES a buy right now?
Sign in free for the AI verdict with entry zone, targets and stop-loss.
About Advanced Enzyme Technologies Limited
Stored fundamentals as of 14 Nov 2026 — not a live quote. Signed-in analysis uses same-day data.
ADVENZYMES key facts
| Price and valuation | |
|---|---|
| Share price | ₹284.00 |
| Market cap | ₹3,107 Cr |
| P/E ratio | 19.1 |
| P/B ratio | 1.91 |
| EPS | ₹15.26 |
| Book value per share | ₹149.00 |
| Dividend yield | 1.89% |
| 52-week range | |
| 52-week high | ₹419.00 |
| 52-week low | ₹246.80 |
| Face value | ₹2.00 |
| Shareholding pattern | |
| Promoters | 43.56% |
| FIIs | 26.64% |
| DIIs | 1.89% |
| Public | 27.9% |
Index membership: NIFTY Microcap 250.
Learn to read these numbers
- Metrics glossary — what P/E, ROE, ROCE and debt-to-equity mean.
- Investment Blogs — free lessons on fundamental and technical analysis.
- AI stock picks and Discover stocks by sector and index.
- How Stock-Analyze works — what the AI analysis and verdict cover.